Series A Fundraising
Paris, April 29, 2019 - KEEN EYE raises EUR 6 Million to empower biomedical labs with AI. This funding will enable the company to deploy internationally its latest machine learning technologies for laboratories and biomedical research.
67th Annual Scientific Meeting of American Society of Cytopathology
Salt Lake City, Nov 14-17, 2019 - Sylvain Berlemont, CEO of KEEN EYE, will be delighted to speak about 'Improving Cytology Slide Screening using Annotation-free Learning'.
Journées de l'Innovation en Biologie
Paris, Nov 21-22, 2019 - KEEN EYE Team will attend to JIBs. Stop by our booth #59 for more infos on our solutions. Paul Bioche, our Key Success Manager, will present a pitch innovation on Thursday 21 at 14:15pm. Paul Klein, one of our data scientist, will make an oral communication about our collaboration with HEGP on biomarkers quantification on Friday at 11:45am.
Colloque 'Intelligence Artificielle et Santé'
Paris, Nov 25, 2019 - We will attend 'Artificial Intelligence and Health' conference at Faculté Paris Sud - Le Kremlin Bicêtre. Stop by our booth for more infos on our solutions!
World Vaccine & Immunotherapy
San Francisco, Dec 2-5, 2019 - Meet Sylvain Berlemont at World Vaccine & Immunotherapy. Let's discuss about 'Integrating the technologies revolutionising immunotherapy and its impact on vaccines development'.
Digital Pathology & AI Congress
London, Dec 4-6, 2019 - Pauline Crépel, one of our business development manager, will attend Digital Pathology & AI Congress. We are excited to listen and share ideas on AI technologies.
Geneva, Dec 11-14, 2019 - Meet the KEEN EYE Team to discuss about the potential of your predictive biomarkers in immuno-oncology. Connect with us to chat!
They are talking about Keen Eye
Keen Eye: Fighting Cervical Cancer: A Deep Learning Solution to Help the Screening of the Disease
Keen Eye and Iris Pharma team up to bring Artificial Intelligence in Ophthalmology studies
HalioDx and Keen Eye partner to empower IMMUNOSCORE® with Artificial Intelligence